Second Sight's Argus II is a FDA-approved bionic eye invention that is said to improve the sight of the visually impaired. The revolutionary product is a device that is mounted to one's glasses and is equipped with a miniature camera that captures a scene.
Once captured, its video is transferred and transmitted wirelessly to the product's accompanying eye implant. Once given a series of corresponding signals, one's retina cells are stimulated, resulting in an image that would otherwise be impossible to see.
After getting used to Second Sight's Argus II bionic eye, patients will learn to interpret visual patterns in a way that mimics real sight. This high tech concept is a revolutionary invention in the world of vision repair and will transform the optometry field. Thanks to the product, the blind are no longer limited to permanent sight loss and have hope toward a brighter future.
Bionic Eye Implants
Second Sight's Argus II Gives The Gift of Vision to the Blind
Trend Themes
1. Bionic Eye Technology - The development of bionic eye technology presents opportunities for disruptive innovation in the field of vision restoration and optometry.
2. Smart Glasses - The integration of miniature cameras and wireless transmission in smart glasses opens up possibilities for disruptive innovation in wearable technology.
3. Retinal Stimulation - Advancements in retinal stimulation technology create disruptive innovation opportunities for the improvement of human visual capabilities.
Industry Implications
1. Optometry - The bionic eye technology developed by Second Sight has the potential to disrupt the traditional practices and treatment options in the optometry industry.
2. Wearable Technology - The integration of bionic eye technology into smart glasses can disrupt the wearable technology industry by providing enhanced visual capabilities to users.
3. Medical Devices - Retinal stimulation technologies like the Argus II bionic eye disrupt the medical devices industry by offering groundbreaking solutions for people with visual impairments.